Evidence map›Paper›PMID 31914612›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2020

A bioassay system of autologous human endothelial, smooth muscle cells, and leukocytes for use in drug discovery, phenotyping, and tissue engineering.

Blerina Ahmetaj-Shala, Ryota Kawai, Isra Marei, Zacharoula Nikolakopoulou, Chih-Chin Shih, Bhatti Konain, Daniel M Reed, Róisín Mongey, Nicholas S Kirkby, Jane A Mitchell

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. A bioassay system of autologous human endothelial, smooth muscle cells, and leukocytes for use in drug discovery, phenotyping, and tissue engineering.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Blerina Ahmetaj-ShalaCardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.
Ryota KawaiCardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.
Isra MareiCardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.
Zacharoula NikolakopoulouCardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.
Chih-Chin ShihDepartment of Pharmacology, National Defense Medical Center, Taipei, R.O.C., Taiwan.
Bhatti KonainCardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.
Daniel M ReedCardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.
Róisín MongeyCardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.
Nicholas S KirkbyCardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.
Jane A MitchellCardiothoracic Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.
Imperial College London · GBLung Institute · USDaiichi-Sankyo (Japan) · JPNational Defense Medical Center · TWNIHR Imperial Biomedical Research Centre · GB

Funding

British Heart Foundation FS/16/1/31699British Heart Foundation PG/16/83/32467
6 · The paper itself

Abstract

Blood vessels are comprised of endothelial and smooth muscle cells. Obtaining both types of cells from vessels of living donors is not possible without invasive surgery. To address this, we have devised a strategy whereby human endothelial and smooth muscle cells derived from blood progenitors from the same donor could be cultured with autologous leukocytes to generate a same donor "vessel in a dish" bioassay. Autologous sets of blood outgrowth endothelial cells (BOECs), smooth muscle cells (BO-SMCs), and leukocytes were obtained from four donors. Cells were treated in monoculture and cumulative coculture conditions. The endothelial specific mediator endothelin-1 along with interleukin (IL)-6, IL-8, tumor necrosis factor α, and interferon gamma-induced protein 10 were measured under control culture conditions and after stimulation with cytokines. Cocultures remained viable throughout. The profile of individual mediators released from cells was consistent with what we know of endothelial and smooth muscle cells cultured from blood vessels. For the first time, we report a proof of concept study where autologous blood outgrowth "vascular" cells and leukocytes were studied alone and in coculture. This novel bioassay has usefulness in vascular biology research, patient phenotyping, drug testing, and tissue engineering.

Indexed as

Biological AssayCells, CulturedCoculture TechniquesCytokinesDrug DiscoveryEndothelial CellsHumansInterleukin-6LeukocytesMuscle, Smooth, VascularMyocytes, Smooth MusclePhenotypeTissue EngineeringTumor Necrosis Factor-alphaCytokinesInterleukin-6Tumor Necrosis Factor-alphablood vesselcytokine responsestem cells

Identifiers

PMID31914612
PMCPMC6972557
OpenAlexW2993722922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.